Piceid as a promising candidate for multi-target adjunctive therapeutic for inflammation-associated cervical cancer progression: an in silico approach

Shamanth D Harishkumar, Shuaib Pasha, Bhavana Harendra, Chandan Dharmashekar, Anisha Jain, Shivananju Nanjunda Swamy, Shiva Prasad Kollur, Chandan Shivamallu, Bhargav Shreevatsa

Open source

DOI
10.1007/s40203-026-00600-z
Published
2026-04-17
Container
In Silico Pharmacology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40203-026-00600-z,
  title = {Piceid as a promising candidate for multi-target adjunctive therapeutic for inflammation-associated cervical cancer progression: an in silico approach},
  author = {Shamanth D Harishkumar and Shuaib Pasha and Bhavana Harendra and Chandan Dharmashekar and Anisha Jain and Shivananju Nanjunda Swamy and Shiva Prasad Kollur and Chandan Shivamallu and Bhargav Shreevatsa},
  year = {2026},
  journal = {In Silico Pharmacology},
  doi = {10.1007/s40203-026-00600-z},
  url = {https://doi.org/10.1007/s40203-026-00600-z}
}

RIS

TY  - JOUR
TI  - Piceid as a promising candidate for multi-target adjunctive therapeutic for inflammation-associated cervical cancer progression: an in silico approach
AU  - Shamanth D Harishkumar
AU  - Shuaib Pasha
AU  - Bhavana Harendra
AU  - Chandan Dharmashekar
AU  - Anisha Jain
AU  - Shivananju Nanjunda Swamy
AU  - Shiva Prasad Kollur
AU  - Chandan Shivamallu
AU  - Bhargav Shreevatsa
PY  - 2026
JO  - In Silico Pharmacology
DO  - 10.1007/s40203-026-00600-z
UR  - https://doi.org/10.1007/s40203-026-00600-z
ER  - 

APA

Harishkumar, S. D., Pasha, S., Harendra, B., Dharmashekar, C., Jain, A., Swamy, S. N., Kollur, S. P., Shivamallu, C., & Shreevatsa, B. (2026). Piceid as a promising candidate for multi-target adjunctive therapeutic for inflammation-associated cervical cancer progression: an in silico approach. In Silico Pharmacology. https://doi.org/10.1007/s40203-026-00600-z

Source records